Drug-Induced Liver Injury Network (DILIN) United States of America (USA)
Research
Date range: 1 March 2023 - 29 February 2024
Research collaboration: Drug-Induced Liver Injury Network (DILIN) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
Drug-Induced Liver Injury Network (DILIN) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Albert Einstein College of Medicine (Einstein)
- Atrium Health
- Duke University Health System
- Icahn School of Medicine at Mount Sinai (ISMMS), MSHS
- Indiana University - Purdue University Indianapolis (IUPUI)
- NIH National Cancer Institute (NCI)
- NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- The University of North Carolina at Chapel Hill (UNC)
- Thermo Fisher Scientific Inc.
- UNC Health Care System
- University of California, Los Angeles (UCLA)
- University of Connecticut (UConn)
- University of Michigan (U-M)
- University of Southern California (USC)